Schroder Investment Management Group
MYOK

Schroder Investment Management Group’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Schroder Investment Management Group’s Portfolio MYOK Stock Details MYOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,795
Closed -$4.3M – 1529
2020
Q3 		$4.3M Buy
30,795
+2,623
+9% +$279K 0.01% 752
2020
Q2 		$2.72M Buy
28,172
+6,252
+29% +$522K ﹤0.01% 772
2020
Q1 		$1.05M Buy
21,920
+43
+0.2% +$2.75K ﹤0.01% 901
2019
Q4 		$1.59M Sell
21,877
-319
-1% -$19.3K ﹤0.01% 914
2019
Q3 		$1.14M Sell
22,196
-20,440
-48% -$1.09M ﹤0.01% 969
2019
Q2 		$2.14M Buy
42,636
+21,318
+100% +$1.04M ﹤0.01% 922
2019
Q1 		$1.11M Hold
21,318
– – ﹤0.01% 881
2018
Q4 		$1.04M Hold
21,318
– – ﹤0.01% 866
2018
Q3 		$1.39M Buy
+21,318
New +$1.25M ﹤0.01% 861

Schroder Investment Management Group's MYOK Position: Q4 2020 in Review

Schroder Investment Management Group sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 30,795 shares — an estimated $4.3M sold.

Schroder Investment Management Group first reported a position in MYOK in Q3 2018 and held it in 9 quarters. The position peaked at $4.3M in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

  • Schroder Investment Management Group reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
  • Schroder Investment Management Group sold 30,795 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $4.3M.
  • Schroder Investment Management Group first reported a position in MyoKardia, Inc. Common Stock in Q3 2018 and held it in 9 quarters.
  • Schroder Investment Management Group's MyoKardia, Inc. Common Stock position peaked at $4.3M in Q3 2020.
  • 0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Schroder Investment Management Group's 13F filing for Q4 2020, filed 16 Feb 2021.